Anatara Lifesciences is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Our lead product Detach™ is a natural product that will help address global concerns around the overuse of antibiotics in animals and their feed that is contributing to the rise of so-called “super bugs” that make infectious diseases harder to treat. The Anatara team has a strong track record in biological science as well as building and growing international biotech companies.
Latest news All news
Anatara Lifesciences wishes to update the description of item 1.8 in the Company’s Appendix 4C for the period ending 31 March 2017, which was released to market this morning.
Please click here to view the ASX announcement and updated quarterly report.
Anatara Lifesciences is pleased to release its Appendix 4C Quarterly Financial Report for the quarter ended 31 March 2017.
Please click here to view the ASX announcement.